OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 365-370
Open Access | Times Cited: 11
Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 365-370
Open Access | Times Cited: 11
Showing 11 citing articles:
Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Lucas E. Hermans, Chijioke N. Umunnakwe, Samanta Tresha Lalla‐Edward, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e553-e560
Open Access | Times Cited: 15
Lucas E. Hermans, Chijioke N. Umunnakwe, Samanta Tresha Lalla‐Edward, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e553-e560
Open Access | Times Cited: 15
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
Aida N. Kawuma, Roeland E. Wasmann, Phumla Sinxadi, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 6, pp. 821-830
Open Access | Times Cited: 7
Aida N. Kawuma, Roeland E. Wasmann, Phumla Sinxadi, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 6, pp. 821-830
Open Access | Times Cited: 7
The Hepatoprotective Effects of Moringa oleifera against Antiretroviral-Induced Cytotoxicity in HepG2 Cells: A Review
Mbasakazi Saki, Helena De Villiers, Claudia Ntsapi, et al.
Plants (2023) Vol. 12, Iss. 18, pp. 3235-3235
Open Access | Times Cited: 7
Mbasakazi Saki, Helena De Villiers, Claudia Ntsapi, et al.
Plants (2023) Vol. 12, Iss. 18, pp. 3235-3235
Open Access | Times Cited: 7
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention
Matthew A. Spinelli, Monica Gandhi
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 169-175
Closed Access | Times Cited: 2
Matthew A. Spinelli, Monica Gandhi
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 169-175
Closed Access | Times Cited: 2
Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
Derin Sevenler, Xin Niu, Sandy Dossantos, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 77, Iss. 4, pp. 996-999
Open Access | Times Cited: 6
Derin Sevenler, Xin Niu, Sandy Dossantos, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 77, Iss. 4, pp. 996-999
Open Access | Times Cited: 6
Vitamin D and Calcium Supplementation Reverses Tenofovir-Caused Bone Mineral Density Loss in People Taking ART or PrEP: A Systematic Review and Meta-Analysis
Xiaoyan Bi, Fan Liu, Xiangjun Zhang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 4
Xiaoyan Bi, Fan Liu, Xiangjun Zhang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 4
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine
Sylvain Chawki, Lauriane Goldwirt, Mayssam El Mouhebb, et al.
AIDS (2023) Vol. 38, Iss. 4, pp. 455-464
Open Access | Times Cited: 2
Sylvain Chawki, Lauriane Goldwirt, Mayssam El Mouhebb, et al.
AIDS (2023) Vol. 38, Iss. 4, pp. 455-464
Open Access | Times Cited: 2
Inflammatory properties of tenofovir in human liver cells
Songezo Vazi, Sanet van Zyl, Roné Vorster -de Wet, et al.
Health Sciences Review (2023) Vol. 8, pp. 100114-100114
Open Access | Times Cited: 1
Songezo Vazi, Sanet van Zyl, Roné Vorster -de Wet, et al.
Health Sciences Review (2023) Vol. 8, pp. 100114-100114
Open Access | Times Cited: 1
Update on Managing the Risks of Exposure to Lentiviral and Retroviral Vectors
Gary R. Fujimoto, Dawn P. Wooley, Karen B. Byers, et al.
Journal of Occupational and Environmental Medicine (2024) Vol. 66, Iss. 10, pp. 818-825
Open Access
Gary R. Fujimoto, Dawn P. Wooley, Karen B. Byers, et al.
Journal of Occupational and Environmental Medicine (2024) Vol. 66, Iss. 10, pp. 818-825
Open Access
In vitro antiviral activity of currently available drugs against primary HIV isolates with high growth capability
Alfredo A. Hinay, K Kanai, Akeno Tsuneki-Tokunaga, et al.
Research Square (Research Square) (2022)
Closed Access
Alfredo A. Hinay, K Kanai, Akeno Tsuneki-Tokunaga, et al.
Research Square (Research Square) (2022)
Closed Access
Point-of-care semiquantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
Derin Sevenler, Xin Niu, Sandy Dossantos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Derin Sevenler, Xin Niu, Sandy Dossantos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
